2024 News Release

NHI Drug Price Revision for FY2025

Participation in "Kusuri Visionary Meeting 2024"
Aiming for Dialogue and Co-creation Among Diverse Stakeholders

Joint Statement by the Three Pharmaceutical Manufacturers' Associations of Japan, the U.S. and Europe
Opinion on the Fiscal 2025 (FY2025) NHI Mid-Year Price Revision and National Strategy

About "Survey on Healthcare Professionals' Concerns in Rare Diseases

JPMA Code of Practice "Code Understanding Promotion Month

JPMA Chairman's Press Conference held on October 8

JPMA 2nd (FY 2024) "Open Call for Researcher Support and Subsidy

Approaches to Eliminate Drug Losses" proposed by the MHLW's Study Council on Unapproved and Off-label Drugs of High Medical Need

In response to the "13th Asian Pharmaceutical Manufacturers Association Conference

The 13th Asian Pharmaceutical Association Conference (APAC) Press Conference

Educational Event in the Pharmaceutical and Medical Fields "Living with Illness. Living with Hope. Photo Exhibition: "Living with Disease, Living with Hope: Toward a Future that Produces Unseen Answers," Part 2 to be Held in Osaka

JPMA Chairman's Press Conference held on February 15, 2012